Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-08Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 AdultsResearch Square · 2026-06-01Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometryJournal of Analytical Toxicology · 2026-05-26Psilocybin’s Kinematic Effect on Manual DexterityResearch Square · 2026-04-14Participant Experiences of Therapeutic Touch in Psilocybin-Assisted TherapyBrain and Behavior · 2026-01-31A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy ParticipantsmedRxiv · 2025-12-22Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot studyActa Neuropsychiatrica · 2025-11-03Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trialTherapeutic Advances in Psychopharmacology · 2025-08-31The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.Therapeutic advances in psychopharmacology · 2024-12-31ALSUntangled #77: Psilocybin.Unknown journal · 2024-12-21Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy ParticipantsPsychiatric Research and Clinical Practice · 2024-07-22Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.BMJ Open · 2021-11-30Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.Australian & New Zealand Journal of Psychiatry · 2021-03-20Dimensions of consciousness and the psychedelic state.Neuroscience of Consciousness · 2018-09-18High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.Unknown journal · 2012-04-12The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.Biological Psychiatry · 2010-12-02Psilocybin slows binocular rivalry switching through serotonin modulationJournal of Vision · 2010-03-18Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptorsJournal of Vision · 2010-03-16Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.Psychopharmacology · 2007-09-13Effects of psilocybin on time perception and temporal control of behaviour in humans.Queensland's institutional digital repository (The University of Queensland) · 2006-05-18Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.Journal of Cognitive Neuroscience · 2005-09-30Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.Unknown journal · 2005-05-31Psilocybin impairs high-level but not low-level motion perception.Unknown journal · 2004-07-31The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection ThresholdsQueensland's institutional digital repository (The University of Queensland) · 2003-12-31A double-blind, placebo controlled study of the effect of the hallucinogenic 5-HT1A&2A agonist psilocybin on binocular rivalry rate and rhythmicitySocial Neuroscience · 2002-12-31